Gene · 8717
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. | J Hematol Oncol | 2022 | 36482419 | PubTator, text mining | PubMed |
| Luteolin: a flavonoid with a multifaceted anticancer potential. | Cancer Cell Int | 2022 | 36482329 | PubTator, text mining | PubMed |
| The dichotomous outcomes of TNFα signaling in CD4+ T cells. | Front Immunol | 2022 | 36466853 | PubTator, text mining | PubMed |
| Immunomodulatory role of metalloproteinase ADAM17 in tumor development. | Front Immunol | 2022 | 36466812 | PubTator, text mining | PubMed |
| Primary cilia suppress Ripk3-mediated necroptosis. | Cell Death Discov | 2022 | 36460631 | PubTator, text mining | PubMed |
| A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. | Dis Markers | 2022 | 36438905 | PubTator, text mining | PubMed |
| Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses. | Int J Mol Sci | 2022 | 36430369 | PubTator, text mining | PubMed |
| Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. | Int J Mol Sci | 2022 | 36430344 | PubTator, text mining | PubMed |
| Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review. | Int J Mol Sci | 2022 | 36430164 | PubTator, text mining | PubMed |
| Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone. | Pharmaceuticals (Basel) | 2022 | 36422548 | PubTator, text mining | PubMed |
| EBV-associated diseases: Current therapeutics and emerging technologies. | Front Immunol | 2022 | 36389670 | PubTator, text mining | PubMed |
| Modulation of Host Antiviral Innate Immunity by African Swine Fever Virus: A Review. | Animals (Basel) | 2022 | 36359059 | PubTator, text mining | PubMed |
| Microglial Dysfunction in Neurodegenerative Diseases via RIPK1 and ROS. | Antioxidants (Basel) | 2022 | 36358573 | PubTator, text mining | PubMed |
| Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells: A Review. | Mar Drugs | 2022 | 36354997 | PubTator, text mining | PubMed |
| Macrophages in periodontitis: A dynamic shift between tissue destruction and repair. | Jpn Dent Sci Rev | 2022 | 36340583 | PubTator, text mining | PubMed |
| Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy. | Front Pharmacol | 2022 | 36339601 | PubTator, text mining | PubMed |
| Necroptosis: A new target for prevention of osteoporosis. | Front Endocrinol (Lausanne) | 2022 | 36339402 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation. | Nat Commun | 2022 | 36329033 | PubTator, text mining | PubMed |
| Major pathways involved in macrophage polarization in cancer. | Front Immunol | 2022 | 36325334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8717/papers?page=20